The A PLUS Act (HR 631) allows states to consolidate federal education funds into a single funding stream, reducing administrative burdens for school districts. It requires states to submit a "declaration of intent" outlining which programs they’ll bundle (excluding special education funds), report annual student progress data to parents, and ensure federal funds supplement - rather than replace - state education spending. States must limit administrative costs to 1% of consolidated funds (3% if excluding Title I) and maintain public accountability through transparent reporting on achievement gaps and funding use. The act directly affects states, school districts, and students - particularly disadvantaged groups - by streamlining fund management while mandating public reporting on educational outcomes.
The Strategic Production Response Act (HR 21) requires the Secretary of Energy to develop a plan increasing oil and gas leasing on federal lands (managed by Interior, Agriculture, Energy, and Defense) by the same percentage as any initial drawdown of petroleum from the Strategic Petroleum Reserve. This plan must be created before the first sale, exchange, or loan of reserve oil, and cannot increase leasing on federal lands by more than 10% overall. The bill mandates consultation with the Secretaries of Agriculture, Interior, and Defense during plan development. It directly affects federal land management agencies and future oil/gas leasing decisions on public lands.
This resolution expresses support for the Supreme Court's holding in Dobbs v. Jackson Women's Health Organization (that there is no constitutional right to abortion). The resolution also applauds the courage of the Justices for standing by their allegiance to the Constitution and the legitimacy of the Supreme Court, and it expresses a commitment to supporting policies that continue to protect all life.
HR 605, the Special Drawing Rights Oversight Act of 2023, requires the U.S. government to seek congressional approval before allocating IMF reserve assets (SDRs) to certain countries. It strengthens oversight by extending consultation periods with Congress from 90 to 180 days, requiring 25% of U.S. IMF quotas to be considered in decisions, and adding new prohibitions: no SDR allocations may be made to countries the President identifies as having committed genocide or repeatedly supported international terrorism without specific congressional authorization. The bill directly affects the U.S. Treasury and President, who currently have authority to approve such allocations without Congress. This changes current practice, which allows unilateral Treasury decisions that could provide billions in unconditional liquidity to countries like China, Russia, Iran, and Venezuela.
Prohibiting Abortion Industry's Lucrative Loopholes Act This bill expands the prohibition on the sale or purchase of human fetal tissue in interstate commerce to include any payments associated with the transportation, implantation, processing, preservation, quality control, or storage of such tissue.
Protecting Life and Integrity in Research Act of 2023 This bill restricts research that uses human fetal tissue from an induced abortion. Specifically, it prohibits the Department of Health and Human Services from conducting or supporting such research. Additionally, the bill applies requirements on the research of transplantation of fetal tissue for therapeutic purposes to research on fetal tissue in general. The bill also prohibits soliciting or acquiring a donation of human fetal tissue from an induced abortion, other than for purposes of an autopsy or burial.
Protecting Life and Taxpayers Act of 2023 This bill requires federally funded entities to certify that they will not, subject to certain exceptions, perform abortions or provide funding to other entities that perform abortions. The bill provides exceptions for abortions (1) in cases of rape or incest; or (2) when the life of the woman is in danger due to a physical disorder, injury, or illness.
This bill prohibits federal funding to Planned Parenthood Federation of America and its affiliates for one year unless they certify they won't perform or fund abortions (with exceptions for rape/incest or life-threatening conditions). It redirects $235 million in existing funding to community health centers for women's health services like contraception, cancer screenings, and prenatal care. The bill explicitly states that redirected funds will continue to support all women's health services previously provided by Planned Parenthood. It also requires repayment of funds if Planned Parenthood violates the certification, and clarifies that overall federal funding for women's health services remains unchanged.
The Educational Choice for Children Act creates tax credits for individuals and corporations that contribute to scholarship organizations providing educational scholarships. Individuals can claim a credit up to 10% of their adjusted gross income or $5,000, while corporations can claim up to 5% of taxable income. Scholarships are available to students in households earning no more than 300% of the area median income and can be used for public or private school expenses, including religious schools. The bill establishes a $10 billion annual cap on total contributions with funds allocated on a first-come, first-served basis, and requires scholarship organizations to verify student income and distribute scholarships to multiple students. It also prohibits government control over scholarship organizations and schools, ensuring maximum freedom for these organizations.
This bill prohibits the FDA from approving new abortion drugs and restricts existing approved drugs to in-person administration by certified healthcare providers. It requires providers to be certified in pregnancy assessment, ectopic pregnancy diagnosis, and emergency care capabilities, and mandates that drugs can only be dispensed in clinics, offices, or hospitals. The bill also imposes new reporting requirements for adverse events (like hospitalizations or severe infections) and requires providers to document risks to patients before prescribing. These provisions apply to all drugs defined as "abortion drugs" under the bill, which includes any substance intended to terminate pregnancy (excluding specific medical exceptions).
This bill prohibits U.S. federal funding for gain-of-function research on certain viruses. It directly affects universities and research institutions that conduct such research, banning new federal grants for them. The law defines gain-of-function research as work that could make influenza, MERS, or SARS viruses more dangerous or contagious in any organism. Federal agencies must stop awarding new grants to institutions performing this specific type of research.
This bill requires the U.S. government to prioritize payments for Social Security benefits, military pay, veterans' benefits, Medicare, and debt held by the public if the national debt reaches its legal limit. It mandates that the Treasury automatically increase the debt ceiling by the amount needed to cover these priority payments during any two-week period where revenue would otherwise fall short. The law directly affects Social Security recipients, active-duty military personnel, veterans, Medicare beneficiaries, and holders of U.S. Treasury debt. Key provisions include automatic debt limit adjustments based on revenue projections and holding excess funds for future payment periods. The bill aims to prevent default on these critical obligations without requiring new congressional action during debt limit crises.
